AstraZeneca Other Non-Current Liabilities 2010-2024 | AZN

AstraZeneca other non-current liabilities for the quarter ending September 30, 2024 were $3.270B, a 6.78% decline year-over-year.

  • AstraZeneca other non-current liabilities for 2023 were $3.825B, a 28.24% decline from 2022.
  • AstraZeneca other non-current liabilities for 2022 were $5.33B, a 10.18% decline from 2021.
  • AstraZeneca other non-current liabilities for 2021 were $5.934B, a 11.03% decline from 2020.

AstraZeneca Other Non-Current Liabilities 2010-2024 | AZN

  • AstraZeneca other non-current liabilities for 2023 were $3.825B, a 28.24% decline from 2022.
  • AstraZeneca other non-current liabilities for 2022 were $5.33B, a 10.18% decline from 2021.
  • AstraZeneca other non-current liabilities for 2021 were $5.934B, a 11.03% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B